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ABSTRACT
Objective: Gold nanoparticles (AuNPs) have been developed as a promising effective site-specific drug to increase drug efficacy and reduce potential 
side effects. However, AuNPs are unstable because they easily aggregate. This study aims to produce stable resveratrol (RSV)-conjugated AuNPs using 
polyvinyl alcohol (PVA).
Methods: AuNPs were synthesized using the Turkevich method, which involves the reduction of chloroauric acid with sodium citrate as a reductor. 
AuNPs were then modified with PVA as a stabilizing agent and conjugated with RSV as a drug model in the carrier system. The formed conjugates were 
characterized using ultraviolet–visible spectrophotometry, Fourier transform infrared spectroscopy, particle size analysis, and high-performance 
liquid chromatography. Furthermore, stability tests were performed in various media (2% bovine serum albumin [BSA], 1% cysteine, phosphate-
buffered saline [PBS] pH 4, PBS pH 7.4, and 0.9% NaCl) for 28 days.
Results: RSV–AuNPs–PVA had a particle size of 78.75 nm, with polydispersity index (PDI) of 0.356, zeta potential of −36.1 mV, and highest entrapment 
efficiency of 78.1%±0.7. RSV–AuNPs without PVA stabilization had a particle size of 51.97 nm, with PDI of 0.694 and zeta potential of −24.6 mV. The 
results of the stability tests demonstrated that RSV–AuNPs–PVA was stable in 2% BSA, PBS pH 7.4, PBS pH 4, and NaCl 0.9% and were unstable in 1% 
cysteine. RSV–AuNPs without PVA were stable in 2% BSA and PBS pH 7.4 and unstable in 1% cysteine, PBS pH 4, and 0.9% NaCl.
Conclusion: PVA can improve the physical stability of RSV-AuNPs conjugates.
Keywords: Conjugate, Gold nanoparticles, Polyvinyl alcohol, Resveratrol, Stability.
INTRODUCTION
Nanomaterial preparations using different noble metals are used in a 
wide variety of biomedical applications due to their unique physical and 
chemical properties; for example, as drug carriers for targeted delivery 
in cancer treatment, for molecular imaging, gene therapy, and in other 
applications, such as biosensors [1]. Nanoparticles have several advantages, 
such as improvement in the intracellular infiltration, circulation time of the 
drug, and enhanced hydrophobic solubility [2]. Nanoparticles are usually 
<100 nm in size. They consist of different biodegradable materials such 
as natural or synthetic polymers, lipids, or metals [3]. Gold nanoparticles 
(AuNPs) have a great potential to be used in effective targeted drug 
delivery because they are easily synthesized, biocompatible, nontoxic, 
and, due to their negative charge, can be easily functionalized by all kinds 
of biomolecules [4]. In general, AuNPs are synthesized by the chemical 
reduction of chloroauric acid (HAuCl4) using reducing agents, such as 
sodium citrate and sodium borohydride [5]. AuNPs have sizes ranging from 
1 to 100 nm [6]. Although gold appears yellow, at the nanoscale level, it can 
appear red, purple, or blue, based on the size of the AuNP [7].
AuNPs are generally unstable due to their high surface energy and 
can often aggregate due to the high ionic strength of many biological 
fluids [8]. Therefore, a suitable stabilizer should be added to prevent 
aggregation. Polyvinyl alcohol (PVA) acts as a stabilizer to prevent 
aggregation by decreasing the surface energy of AuNPs and minimizing 
Van der Waals attraction [9]. PVA has remained a promising choice for 
AuNP stabilization due to its biocompatibility, water solubility, and 
hydroxyl fill nature [10].
Resveratrol (RSV) (3,5,4’-trihydroxystilbene) is a polyphenol 
compound found in different medicinal plants. RSV has antioxidant, 
anti-inflammatory, and anti-senescence properties, and potential as an 
anticancer drug. It inhibits cell growth, tumor proliferation, invasion, 
metastasis, and angiogenesis by downregulating many molecular 
signaling targets [11]. RSV–AuNP can inhibit the signaling of molecules 
involved in breast cancer invasions, such as MMP-9, COX-2, NF-κB, and 
AP-1 [12]. The inhibitory effect is stronger than that of a single RSV 
molecule at the same concentration. Thus, RSV has been potentially 
developed as a drug model with anticancer activity.
In this research, the aim was to produce a PVA-stabilized AuNP 
as a targeted drug delivery system with RSV as a drug model. The 
formed RSV–AuNPs–PVA was evaluated by physical stability tests and 
characterized by ultraviolet (UV)–visible spectrophotometry, Fourier 
transform infrared (FTIR) spectroscopy, particle size analysis, and high-
performance liquid chromatography (HPLC).
MATERIALS AND METHODS
Materials
RSV, chloroauric acid, PVA (Mowiol® 8–88, Mw 67,000), phosphate-
buffered saline (PBS), cysteine, and bovine serum albumin (BSA) were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Sodium chloride, 
methanol, ethanol, acetonitrile, and sodium citrate were purchased 
from Merck (Germany). Distilled water and aqua bidest were also used.
Synthesis of RSV–AuNPs–PVA and RSV–AuNPs
The aqueous solution of HAuCl4.3H2O (1 mM) 25.0 mL was heated to 
approximately 95°C with stirring at 350 rpm. A volume of 0.846 ml 
of 130 mM aqueous sodium citrate solution was rapidly added to the 
solution with stirring. The color of the solution changed instantly from 
pale yellow to colorless, then turned to dark blue and reddish-purple 
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after a few minutes. Stirring and heating were maintained for 15 min 
after the addition of sodium citrate. The heat was then removed, and 
the solution was stirred on the addition of 0.833 ml of 3% w/v PVA 
to the reddish-purple solution. The solution was stirred at 350 rpm 
and cooled at room temperature. Finally, 5.7 ml aqueous RSV solution 
(10 ppm) was added drop-by-drop to the solution and continuously 
stirred at 150 rpm for 2 h at room temperature to obtain PVA-stabilized, 
resveratrol-conjugated gold nanoparticles (RSV–AuNPs–PVA). The 
RSV–AuNPs solution was produced by the same method, but without 
the addition of PVA.
Characterization
Physical appearance of RSV–AuNPs and RSV–AuNPs–PVA
The physical appearance of RSV–AuNPs and RSV–AuNPs–PVA was 
analyzed by physical comparison to observe the differences in color and 
the presence/absence of precipitates at the bottom of the vial.
Measurement of absorbance and wavelength under UV–visible 
spectrophotometry
The absorbance spectrum of RSV–AuNPs and RSV–AuNPs–PVA 
with comparison 1:10 in aquadest was recorded using a UV–visible 
spectrophotometer UV-1800 (Shimadzu, Japan) in the range of 400–
800 nm.
Infrared spectrum analysis using FTIR spectroscopy
The FTIR spectra of standard RSV and standard PVA were determined, 
and the dried samples were ground homogeneously with potassium 
bromide. The infrared spectrum analysis was recorded on an FTIR-
8400S (Shimadzu, Japan) in a wavenumber region of 400–4000 cm−1.
Particle size distribution, polydispersity index (PDI), and zeta potential
The particle size distribution, PDI, and zeta potential of the 
RSVAuNPs and RSV–AuNPs–PVA were determined by dynamic light 
scattering using a Malvern Zetasizer (Nano ZS, Malvern Instruments, 
Worcestershire, UK).
RSV entrapment efficiency
A standard RSV solution of 1000 ppm was prepared in methanol, then 
diluted to 1, 5, 10, 15, 20, and 25 ppm to produce a calibration curve. 
Approximately 2 ml of RSVAuNPsPVA was centrifuged at 12,000 rpm 
at 27°C for 60 min. The supernatant was then filtered through a using 
a filter with a pore size of 0.22 µm and analyzed indirectly using HPLC. 
The amount of RSV trapped in the RSV-AuNPs-PVA was determined 
by subtracting the quantity in the supernatant from the total quantity 
used during the preparation. These analyses were performed in 







Mobile phase = aqua pro injection: acetonitrile (3:1), then glacial acetic 
acid added until pH 3
Flow rate = 1.5 ml/min
Injection volume = 20 µl
Detector = UV–visible at 306 nm
Column = C18.
In vitro stability tests in various media
Typically, 2 ml of sample was redispersed to 1.0 ml of each of the 
following media: 2% BSA, 1% cysteine, 0.9% NaCl, PBS pH 4, and PBS 
pH 7.4. The stability test was carried out for 28 d because the clearance 
of AuNPs took 28 days. In the 1st week, samples were taken daily 
and, for the next 3 w weeks, every 3 days. The stability of AuNPs was 
monitored by recording the absorbance at 400–800 nm with UV–visible 
spectrophotometry. The results were generated by observation of the 
color change and the precipitates formed absorbance change, maximum 
wavelength shift, and the change in full width at half maximum (FWHM) 
value.
RESULTS
Synthesis of AuNP and optimization concentration of PVA as a 
stabilizing agent
The chemical reduction of HAuCl4.3H2O is widely used for the synthesis 
of AuNPs. Sodium citrate (Na3C6H5O7) acts as a reducing agent, where 
Au3+ is reduced to Au0 to form AuNPs. The formation of AuNPs can 
be observed by a change in color from pale yellow to reddish-purple. 
This color change occurs due to surface plasmon resonance, which is 
a specific property of AuNPs. The spectra exhibit an absorption band 
at 528.5 nm, which is a typical plasmon band of AuNPs, indicating 
that AuNPs have formed. The maximum AuNPs absorbance occurred 
at wavelengths from 520 to 565 nm, which corresponds to green and 
purple (Fig. 1) [13].
In the preparation of RSV–AuNPs–PVA, first, the optimization of 
PVA concentration as a stabilizer was determined by varying the 
concentration of PVA (1%, 3%, 5%, 6%, and 7%) and observing the 
absorbance change over 7 days using a UV–visible spectrophotometer. 
The obtained AuNPs stabilized by varying concentrations of PVA were 
then diluted with a ratio of 1:10 using aquadest. The results are shown 
in Fig. 2.
At a concentration of 1%, PVA showed the lowest absorbance, which 
continued to decrease until day 7. The absorbance results showed that 
the 3% PVA concentration had the highest absorbance and the most 
stable UV–visible results over 7 days, while the preparations of AuNPs-
PVA with higher concentrations of PVA (5%, 6%, and 7%) showed lower 
absorbance and fluctuating graphs. Therefore, the optimal condition for 
stabilized AuNPs was determined to be at a PVA concentration of 3%.
Characterization of RSV–AuNPs and RSV–AuNPs–PVA
Physical appearance
The obtained nanoparticle solution was a reddish-purple color, as 
shown in Fig. 3. All the AuNPs were prepared as a clear solution, which 
indicates that the Au was homogenously dispersed [13]. The RSV–
AuNPs had a dark purple color (Fig. 3a), while the RSV–AuNPs–PVA 
had a clear reddish-purple color (Fig. 3b). These color differences were 
found to correlate with the size of the particles formed. The reddish-
purple color signifies that the particles have a small particle size, and 
Fig. 1: Ultraviolet-visible absorption spectrum (528.50 nm) of 
gold nanoparticle
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the darker purple or blue color signifies a larger particle size [14]. 
Larger particles form due to the tendency of aggregation. This result 
showed that the RSV–AuNPs–PVA had a smaller particle size than 
RSV–AuNPs, indicating that PVA acts as a steric stabilizer by creating a 
repulsive barrier to prevent aggregation.
Measurement of absorbance and wavelength using UV–visible 
spectrophotometer
In this study, we observed the absorbance of HAuCl4 1 mM, 10 ppm RSV 
standard, 3% PVA solution, RSV–AuNPs, and RSV–AuNPs–PVA. The UV–
visible spectra of the HAuCl4 solutions before and after the reduction 
of metal ions were measured. In the aqueous solution before reduction, 
HAuCl4 showed a strong absorption band at 290 nm due to charge 
transfer between the metal and chloro ligands [15]. After reduction 
with sodium citrate, the 290 nm band of AuCl4- vanished, indicating that 
AuCl4- was completely reduced. Instead, we observed a new absorption 
band at 529 nm (RSV–AuNPs–PVA) and 534 nm (RSV–AuNPs), which 
could be assigned to a plasmon band of the AuNPs. The PVA solution 
provided maximum absorption at 279.40 nm (Fig. 4).
The maximum absorbance of RSV–AuNPs–PVA was 0.374, higher than 
that of RSV–AuNPs (0.260). The absorbance showed a similar trend 
with the number of AuNPs formed. The higher absorbance indicated 
that more AuNPs were formed [16], indicating that PVA can stabilize 
AuNPs by preventing aggregation.
Particle size distribution, PDI, and zeta potential
The results for particle size, PDI, and zeta potential are shown in 
Table 1. The values suggest that the particle size of both RSV–AuNPs 
and RSV–AuNPs–PVA was in the nanosize range of 1–100 nm [5]. RSV–
AuNPs–PVA particles were found to be bigger than RSV–AuNPs particles 
because dynamic light scattering obtains a hydrodynamic diameter 
based on the diffusion of the particles. If a gold colloid is coated with 
a protective stabilizer then the size measured will be a reflection of 
the core gold and the protective shell; therefore, the particle size is 
increased.
PDI is a parameter that defines particle size distribution. The PDIs of 
RSV–AuNPs and RSV–AuNPs–PVA were 0.694 and 0.356, respectively. 
The closer the PDI value is to zero, the more homogeneous the 
dispersion of particles in the solution [17]. The PDI reflects the stability 
of a nanoparticle system, with a higher value indicating increasing 
particle aggregation and low homogeneity.
The zeta potential of nanoparticles is commonly used to characterize 
their surface charge properties. A zeta potential between −30 mV 
and 30 mV correlates to high stability, as the surface charge prevents 
aggregation of the particles [18]. The zeta potential of RSV–AuNPs–PVA 
was −36.1 mV, which is smaller than −30 mV, so the formulation had 
a good value of zeta potential. The RSV–AuNPs–PVA were found to be 
more stable than the RSV–AuNPs (zeta potential of −24.6 mV), which 
reached the “threshold of delicate dispersion” category defined by the 
American Filtration and Separations Society [19].
RSV entrapment efficiency
The RSV entrapment efficiency reflects the amount of RSV entrapped 
within the AuNPs. The standard calibration curve equation obtained 
was y=92620×−28703 with r=0.9998. The chromatogram showed that 
the retention times of both standard RSV and RSV in the samples were 
Table 1: Physicochemical characterization of gold nanoparticles






RSV-AuNPs 51.97 0.694 −24.6
RSV-AuNPs-PVA 78.75 0.356 −36.1
RSV: Resveratrol, AuNPs: Gold nanoparticles, PVA: Polyvinyl alcohol
Fig. 2: Optimization concentration of polyvinyl alcohol (PVA) 
in the preparation of resveratrol-gold nanoparticles-PVA 
(400–800 nm)
Fig. 4: The spectrum absorbance of HAuCl4 1 mM (a), 3% polyvinyl 
alcohol (PVA) solution (b), 10 ppm resveratrol standard (c), 
resveratrol-gold nanoparticles (RSV-AuNPs)-PVA (d), RSV-AuNPs (e)
Fig. 3: Physical appearance of (a) resveratrol conjugated gold 
nanoparticle (RSV-AuNPs), and (b) resveratrol conjugated gold 
nanoparticle with PVA stabilization (RSV-AuNPs-PVA)
a b
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approximately 14 min. From the results of the calculated data, the mean 
percentage of RSV entrapment efficiency over three measurements was 
78.1%±0.7%.
Infrared spectrum analysis
The FTIR spectra of RSV, PVA, AuNPs, RSV–AuNPs, and RSV–AuNPs–PVA 
are shown in Fig. 5. RSV exhibited prominent bands at wavelengths of 
3380–2925 cm−1 (O–H); 1613 cm−1.
(C=C Alkene); 1583 cm−1 and 1475 cm−1 (C=C Aromatic); and 833 cm−1 
(meta-para substitution). Bands of RSV-AuNP and RSV–AuNPs–PVA 
were observed at 833 cm−1 (meta-para substitution) and 1583 cm−1 
and 1475 cm−1 (C=C Aromatic), suggesting that RSV was present in the 
samples. The PVA exhibited hydroxyl group (O–H) prominent bands at a 
wavelength of 2875.96 cm−1 (C–H) and strong intensity at a wavelength 
of 2357.09 cm−1 (vibration of the O-H group). The FTIR spectra of 
RSV–AuNPs-PVA also showed prominent bands at a wavelength of 
2875.96 cm−1 (C–H), while these were absent in the spectra of AuNP and 
RSV-AuNP. These results suggest that PVA was present in the samples 
and that interaction took place between AuNP and the PVA at the O–H 
groups.
In vitro stability studies of AuNPs
In vitro stability analysis of RSV–AuNPs and RSV–AuNPs–PVA without 
medium (control)
The UV–visible absorbance of RSV–AuNPs–PVA was decreased but not 
significantly compared to the initial absorbance, while RSV–AuNPs 
showed fluctuating change (Fig. 6). The change in wavelength over 
28 days of the RSV–AuNPs (>10 nm) indicated the change in particle 
size in the AuNPs system due to aggregation of the colloid [19]. 
Furthermore, the absorbance spectrum of the RSV–AuNPs–PVA was 
narrower than that of the RSV–AuNPs. This indicates that the FWHM 
value of the RSV–AuNPs–PVA was lower than that of the RSV–AuNPs. 
The instability of RSV–AuNPs was also supported by their change in 
color from reddish-purple to clear when precipitates formed on day 16. 
On day 19, FWHM and wavelength shift could no longer be calculated 
because the peak line reached point zero. Thus, RSV–AuNPs–PVA were 
more stable due to the addition of PVA, which prevents aggregation.
In vitro stability analysis of RSV–AuNPs and RSV–AuNPs–PVA in 2% BSA
Both RSV–AuNPs and RSV–AuNPs–PVA showed stable absorbance 
results (Fig. 7) in 2% BSA. The maximum wavelength shift (λ max) of 
RSV–AuNPs and RSV–AuNPs–PVA did not exceed 10 nm after 28 days, 
indicating the physical stability of the AuNP system. Their stability is also 
supported by their FWHM values, which did not change significantly. It 
can be concluded that both RSV–AuNPs and RSV–AuNPs–PVA are stable 
in 2% BSA medium.
In vitro stability analysis of RSV–AuNPs and RSV–AuNPs–PVA in 1% 
cysteine
RSV–AuNPs were found to unstable in 1% cysteine medium (Fig. 8). 
This instability was demonstrated by the change in the color of the 
RSV–AuNPs solution from reddish-purple to blue; then, 1 h later, to clear 
with precipitates at the bottom of the vial. The RSV–AuNPs absorption 
spectrum was flat from day 0, and the absorbance was low (0.028). The 
FWHM value of RSV–AuNPs was high due to its widened spectrum.
RSV–AuNPs–PVA also showed instability in 1% cysteine medium, 
demonstrated by its decreased absorbance day-by-day. Moreover, the 
maximum wavelength shifts were >10 nm during the observation 
period, and higher FWHM values were observed until day 7. Although 
PVA did not produce great stability in this medium, the results were 
much better than for RSV–AuNPs. Stabilization of AuNPs with PVA can 
prevent aggregation in 1% cysteine medium until day 7 (Fig. 8).
Fig. 5: Fourier transform infrared spectra from top to bottom: resveratrol standard (a), 3% polyvinyl alcohol (PVA) standard (b), gold 
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In vitro stability analysis of RSV–AuNPs and RSV–AuNPs–PVA in PBS at 
various pH conditions
In PBS pH 7.4 medium, RSV–AuNPs and RSV–AuNPs–PVA tended to be 
stable (Fig. 9). Based on the UV–visible spectrum, the absorbance values 
of both RSV–AuNPs and RSV–AuNPs–PVA were relatively stable during 
the observation period. The changes in the λ max of RSV–AuNPs and 
RSV–AuNPs–PVA were <10 nm, and the FWHM values were relatively 
stable.
In PBS pH four medium, RSV–AuNPs clearly showed instability. This was 
demonstrated by the color change from reddish-purple to clear with 
precipitates. From day 0, the absorption spectrum of RSV–AuNPs was 
flat in the region of 500–550 nm with a low absorbance value (0.014). 
Fig. 6: (a-c) Absorbance comparison graph, maximum wavelength (λ max), and full width at half maximum value between resveratrol-gold 
nanoparticles (RSV-AuNPs) with RSV-AuNPs-polyvinyl alcohol without medium
a b
c
Fig. 7: (a-c) Absorbance comparison graph, maximum wavelength (λ max), and full width at half maximum value between resveratrol-gold 
nanoparticles (RSV-AuNPs) with RSV-AuNPs-polyvinyl alcohol in 2% bovine serum albumin
a b
c
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Fig. 8: (a-c) Absorbance comparison graph, maximum wavelength (λ max), and full width at half maximum value between resveratrol-gold 
nanoparticles (RSV-AuNPs) with RSV-AuNPs-polyvinyl alcohol in 1% cysteine
a b
c
Fig. 9: (a-c) Absorbance comparison graph, maximum wavelength (λ max), and full width at half maximum value between resveratrol-gold 
nanoparticles (RSV-AuNPs) with RSV-AuNPs-polyvinyl alcohol in phosphate-buffered saline pH 7.4
a b
c
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Fig. 10: (a-c) Absorbance comparison graph, maximum wavelength (λ max), and full width at half maximum value between resveratrol-
gold nanoparticles (RSV-AuNPs) with RSV-AuNPs-polyvinyl alcohol in phosphate-buffered saline pH 4
a b
c
Fig. 11: (a-c) Absorbance comparison graph, maximum wavelength (λ max), and full width at half maximum value between resveratrol-
gold nanoparticles (RSV-AuNPs) with RSV-AuNPs-polyvinyl alcohol in 0.9% NaCl
a b
c
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The FWHM value of RSV–AuNPs was greater than RSV–AuNPs–PVA due 
to its widened spectrum (Fig. 10).
In vitro stability analysis of RSV–AuNPs and RSV–AuNPs–PVA in PBS 0.9% 
NaCl
The stability test of RSV–AuNPs in 0.9% NaCl solution showed that RSV–
AuNPs were unstable in this medium (Fig. 11), demonstrated by the 
color change of the RSV–AuNPs solution from reddish-purple to deep 
purple. The next day, it turned clear with precipitates. A significant 
decrease in RSV–AuNPs absorbance was also observed. The maximum 
wavelength and FWHM value could not be calculated after day 1, 
because the absorption spectrum of RSV–AuNPs was flat in the region 
of 500–550 nm. The RSV–AuNPs–PVA was stable in 0.9% NaCl medium. 
Based on the spectrum, the absorbance change was relatively stable, 
and the wavelength shift of RSV–AuNPs–PVA was <10 nm. The FWHM 
value of RSV–AuNPs–PVA increased slightly but tended to be stable.
DISCUSSION
One of the most important aspects of the various biomedical applications 
of AuNPs is their stability in physiological media. Aggregation of AuNPs 
represents a key issue that underlies multiple deleterious effects 
in many therapeutic applications, including loss of efficacy, altered 
pharmacokinetics, and induction of unwanted immunogenicity [20]. 
Thus, in vitro stability tests were performed for both RSV–AuNPs and 
RSV–AuNPs–PVA.
Observation using UV–visible spectrophotometry can be used as a 
parameter of physical stability change in AuNPs because a decrease 
in absorbance indicates that particle size is enlarged. Furthermore, 
a change of λ max >10 nm during observation indicates a change in 
particle size of AuNPs due to aggregation of the particles [20].
FWHM is a sensitive measurement for monodispersity. Polydispersity 
produces wider absorbance bands and monodispersity produces 
narrower ones. A low FWHM value indicates monodispersity, while 
higher values indicate polydispersity of particles [21]. The instability of 
AuNPs is augmented by an increasingly widened spectrum with a high 
FWHM value.
In this study, in vitro stability tests of RSV–AuNPs and RSV–AuNPs–
PVA were performed in 2% BSA solution because albumin is the most 
abundant protein in human blood plasma. Stability tests using BSA are 
carried out to obtain an overview of the stability of a drug in human 
blood plasma in vitro [20].
We also conducted in vitro stability tests in a 1% cysteine solution. 
Cysteine was chosen because it has a sulfur atom (thiol group), 
otherwise known as SH. The thiol group in cysteine will bind to AuNPs 
with high affinity [20]. This interaction will cause aggregation of AuNPs, 
characterized by a change color from reddish-purple to blue [22]. 
The aggregation of AuNPs was also characterized by a widened 
spectrum [20].
At neutral pH, the AuNPs solutions maintained their reddish-purple 
color, indicating no aggregation. This is because the citrate was fully 
deprotonated and there were negative surface charges that result in 
repulsion between the nearby AuNPs [23]. Thus, both RSV–AuNPs and 
RSV–AuNPs–PVA were stable in PBS pH 7.4.
At pH <7, citrate is fully protonated, and thus the number of negative 
surface charges is greatly reduced. The decrease in negative surface 
charges results in aggregation and hence decreases the stability of the 
AuNPs [24]. In the presence of fully protonated citrate, PVA can stabilize 
AuNPs in pH 4 PBS. These findings indicate that RSV–AuNPs–PVA was 
physically stable in pH 4 PBS. Further research is needed into the impact 
of stabilization using PVA to the release of drugs in an AuNPs system. At 
pH 4, which is the pH that represents cancer cells, it is expected that the 
drug can release quickly from the system.
NaCl is an electrolyte solution containing cations and anions. NaCl 
0.9% solution can be used in biological studies and in vitro stability 
tests because it contains Na+ and Cl− ions, which are the most abundant 
ions in the body’s cellular system [20]. AuNPs form aggregates in the 
electrolyte solution, causing the particles to increase in size [20].
The results showed that RSV–AuNPs–PVA were stable in 0.9% NaCl 
solution over the 28-day observation period, while RSV–AuNPs were 
only stable for 16 d. This was presumably because PVA had formed a 
steric stabilization, which helped stabilize the AuNPs. However, the 
results of the stability tests in various media showed that RSV–AuNPs–
PVA were more stable in 2% BSA, PBS pH 7.4, PBS pH 4, and 0.9% 
NaCl than RSV–AuNPs and were unstable in 1% cysteine. These results 
suggest that the use of PVA can improve the physical stability of RSV-
AuNPs conjugates.
CONCLUSION
The application of PVA to RSV-conjugated AuNPs was proficient in 
preventing aggregation and consequently could improve the physical 
stability of AuNPs. However, further optimization of other parameters, 
such as stirring time, temperature, and pH, which affect the manufacture 
of RSV–AuNPs–PVA, is needed. Purification of the formed conjugate is 
also required to increase its purity and facilitate quantitative analysis.
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